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Abstract
Objective: We examined the protective effects of ethanolic extract of Lippia citriodora (L. citriodora) on rats subjected 
to chronic constriction injury (CCI) of sciatic nerve and possible mechanisms of actions. 
Materials and Methods: In this experimental study, the extract was administered 50, 100 and 200 mg/kg, Intraperitoneally 
(I.P) from the surgery time for 14 consecutive days. The changes in the spinal cord levels of apoptotic factors, microglia 
and astroglia markers during the time course of study were assessed by western blotting on days 3, 7 and 14 post-CCI. 
Results: CCI rats developed neuropathy evident from a marked mechanical allodynia, cold allodynia and thermal 
hyperalgesia on days 3, 5, 7, 10 and 14 post-CCI. A significant increase in the levels of Iba (a marker of microglia 
activation) and Bax (a proapoptotic factor) was observed three days after nerve injury. The levels of Iba remained high 
on day 7. In contrast, there was no difference in glial fibrillary acidic protein (GFAP) contents between sham and CCI 
animals. Treatment with the extract significantly attenuated behavioral changes associated with neuropathy. Bax/Bcl-2 
and Iba1 were decreased in CCI animals treated with the extract.                     
Conclusion: The results support the evidence that microglial activation and apoptosis are correlated with pain 
behaviors. It is suggested that anti-allodynic and anti-hyperalgesic effects, elicited by L. citriodora, might have some 
degrees of association with the inhibition of microglia activation and apoptotic pathways.          
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Introduction
Chronic neuropathic pain often accompanies nerve 
injury or damage to the nervous system and it can be 
categorized as central or peripheral pain. Important 
manifestations are spontaneous pain, allodynia (a painful 
response to innocuous stimulus), and hyperalgesia 
(increased sensitivity to nociceptive stimulus). As current 
therapies have low efficacy and do not adequately 
alleviate pain (1), further investigations are needed 
for new pain relieving agents with improved side-
effect profiles. There is nowadays a considerable 
interest for natural anti-oxidants in the treatment of 
chronic conditions, such as neuropathic pain (2, 3).
Lippia citriodora, Lippia tryphilla or Aloysia tryphilla 
(verbenaceae), a plant originated from South America, 
was introduced into Europe at the end of the 17th century 
and is now adapted well to the Mediterranean area. Based 
on the region, this plant is variously called, including 
lemon verbena (English), Lousia (Arabic), and Behlimoo 
in Persian. The leaves of this plant are used in different 
types of food and tea due to the lemon-like aroma. Lemon 
verbena has been widely used in folk medicine for treatment 
of various ailments, such as fever, cold, skin infections and 
digestive problems. In addition, lemon verbena has been 
used based on its anti-spasmodic, anti-pyretic and sedative 
effects (4, 5). The main components of this popular herb 
are composed of several iridoids, flavonoids, phenolic 
acids and phenylpropanoids, particularly verbascoside, as 
powerful anti-oxidants. Lippia extracts and verbascoside, 
the most abundant constituent, are known to have various 
pharmacological effects including anti-bacterial (6), anti-
ulcerogenic (7), anti-proliferative (8), anti-oxidant (9-12), as 
well as learning and memory improvement (13). 
Anti-inflammatory and anti-nociceptive effects of this 
plant have been demonstrated in some studies (14-16). In 
recent years, more attention has been paid to the role of 
glial cells (microglia and astroglia) in the pathogenesis of 
neuropathic pain. Furthermore, a growing body of data 
indicates that oxidative stress and apoptosis have a role 
in the induction and development of neuropathic pain 
(17). In this study, we investigated the effect of 14 days 
intraperitoneal (I.P) administration of Lippia citriodora 
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(L. citriodora) ethanolic extract on the behavioral 
parameters of rats, undergoing chronic constriction injury 
(CCI) of neuropathic pain. In addition, the impact of 
this extract was studied in the protein levels of ionized 
calcium binding activated protein 1 1 (Iba1), as a marker 
of microglia activation, glial fibrillary acidic protein 
(GFAP), as a marker of astroglia activation, as well as two 
pro-apoptotic and anti-apoptotic proteins, Bcl2-associated 
X (Bax) and B-cell lymphoma (Bcl2) respectively.
Materials and Methods
In this experimental study, Ketamine and xylazine 
(Alfasan Pharmaceutical Co., Switzerland) were I.P 
injected at dosages of 64 and 1.6 mg/kg, respectively. 
Gabapentin was a gift from Tehran Darou Pharm Co. 
(Iran). Ethanolic extract was obtained in our laboratory. It 
was dissolved in normal saline (0.9%), and administered 
I.P, immediately after preparation at the dosages of 50, 
100 and 200 mg/kg body weight, once a day. Dosage 
selection was based on the previous studies (2, 5, 18). 
Administration of the extracts were started immediately 
after surgery and continued until day 14.
Extract preparation
Identification of the plant was confirmed by botanists in 
the Department of Pharmacognosy, Faculty of Pharmacy, 
Mashhad University of Medical Sciences (Iran). For 
preparing ethanolic extract, the fine powder dried leaves 
(200 g) were macerated in successive portions of ethanol 
(80%, v/v) for 72 hours and the mixture was subsequently 
filtered and concentrated at 50˚C. The yielded extract was 
freeze-dried and stored at -20˚C (19).
High-performance liquid chromatography with a 
diode array detector analysis 
High-performance liquid chromatography-diode array 
detector (HPLC-DAD) was performed on a KNAUER 
liquid chromatograph system consisting of a quaternary 
pump (Smartline Pump 1000, Germany). Detection was 
carried out using UV-visdiode array detector (Smartline 
DAD 2800, Germany), and data were processed using 
Agilent EZChrom Elite software (version 3.3, USA). The 
ethanolic extract was subjected to reverse-phase HPLC 
using a gradient method of 20-100% methanol (A) in 
water as the eluent including 0.05% trifluoroacetic acid. 
The preparative C18 (5 µl, 21.2×250 mm) and flow rate 
(10 ml/minute) were used. The linear gradient program 
was used as follow: 0-10 minute (s), 0-20% methanol; 10-
15 minutes, 20-80% methanol; 15-20 minutes, 80-100% 
methanol; 20-25 minutes, 100% methanol; 25-28 minutes, 
100-20% methanol; 28-30 minutes, 20% methanol. The 
peaks were monitored at 320 nm (20).
These experiments were carried out on adult male Wistar 
rats, 250-270 g in weight. The animals were housed on a 12 
hours alternating light-dark cycle at a temperature of 22 to 
24˚C, in the animal room of the School of Pharmacy, Mashhad 
University of Medical Sciences. Rats were provided with 
standard rodent chow and tap water. Experimental protocol 
was approved by Ethical Committee Mashhad University 
of Medical Sciences (Approval No.: 910351, 11.Aug. 2012) 
and conformed to the Internationally Accepted Principles for 
Laboratory Animal Use and Care (21).
Induction of neuropathic pain
According to the technique of Bennett and Xie (22), one 
sciatic nerve of the animals was constricted. Briefly, in 
rats anesthetized with a cocktail of ketamine and xylazine 
(64/1.6 mg/kg, I.P), the left sciatic nerve was isolated at 
the mid-thigh level by blunt dissection, just proximal to 
its trifurcation and four chromic catgut ligatures (4-0) 
were applied. 
Study of protocol
87 adult male Wister rats were randomly assigned into 
following groups: i. Animals without manipulation (naïve 
animals), ii. CCI animals were treated with normal saline 
(NS) at a dosage of 1 ml/kg (250 µl for a 250 g animal), 
iii. Sham group: animals underwent a surgical procedure, 
without ligature of sciatic nerves, treated with the NS, iv. 
CCI animals were treated with gabapentin as the reference 
drug (100 mg/kg) for 14 days, and v-vii. CCI animals 
were treated with L. citriodora ethanolic extract (50, 100 
and 200 mg/kg, respectively), administered at dosage of 1 
ml/kg for 14 days. On respective days of 3, 7 and 14, the 
lumbar spinal cord of three animals in each group (except 
group 3) was rapidly ejected from the vertebral column 
using a saline-filled syringe, as quickly as possible, and 
then separated on dry ice. The reason of examining the 
L4 and L5 segments was based on the consideration that 
these lumbar segments are the major contributor to the 
sciatic nerve (22).
Behavioral tests
In order to establish baseline values of the nociceptive 
thresholds, pain related behaviors were evaluated at the 
nerve-damage hind paw, one day before operation as 
well as at the 3rd, 5th, 7th, 10th and 14th postoperative days. 
Applied tests were as following order: Von Frey 108 test, 
acetone and finally thermal stimulus.
Von Frey hair withdrawal threshold (mechanical 
allodynia)
A series of calibrated Von Frey filaments (Stoelting, 
Wood Dale, USA), providing forces of 0.6, 1, 2, 4, 6, 8, 10, 
15, 25 and 60 g (cut off=60 grams), were used to measure 
mechanical sensitivity of the injured hind paw. Each rat 
was placed in a small plastic cage with a metal mesh 
floor and allowed to acclimate to their surrounding for 
15 minutes before testing. The filaments were repeatedly 
applied perpendicular to the mid-plantar surface of the 
hind paw in an ascending stiffness order, until it bent. 
Each Von Frey filament was applied five times. When 
rats showed at least three brisk withdrawal responses to 
a filament, the bending force of the filament was defined 
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as the paw withdrawal threshold (PWT). The hind paw 
was tested with at least 30 seconds intervals between 
consecutive stimuli on the injured hind paw (22).
 
Acetone drop withdrawal threshold (cold allodynia)
Cold allodynia was assessed using the acetone drop 
application. Animals were placed in the plexiglas boxes 
and allowed to acclimatize for about 15 minutes. Acetone 
test was performed by touching a single bubble of acetone 
to the mid plantar surface of each injured hind paw from 
the tip of a 1 ml syringe. A positive response was recorded, 
if the animal withdraws the paw following application. 
For each measurement, the paw was sampled five times 
and a mean PWF was calculated. It was elapsed at least 3 
minutes between each test (23).
Withdrawal latency to a noxious heat stimulus (heat 
hyperalgesia
A plantar (Hargreaves) analgesic meter (Ugo Basile, 
Comerio, Italy) (24) was used to assess the latency 
of response to a noxious heat stimulus applied to the 
plantar surface of the injured hind paw. Each rat was 
placed on a 2-mm-thick Plexiglas floor. After 5 minutes of 
acclimatization to the new environment, the laser radiant 
heat source was projected to the plantar surface of the hind 
paw. When animal withdraw its paw, this was detected by a 
photocell and timer was automatically stopped. The stimulus 
onset activated a timer which was automatically stopped, 
upon detecting the evoked paw withdrawal by a photocell. 
Three latency measurements were taken and averaged for 
each hind paw during each session of testing. Reduced 
response of latency to a normally noxious heat stimulus was 
considered to represent hyperalgesia. Two or three minutes 
rest was considered between subsequent tests. 
Tissue preparation
After detection of pain threshold on the respective 
days, three rats from each group were anesthetized and 
sacrificed by decapitation. For the protein extraction, 
the lumbosacral spinal cord segment of animals was 
extracted, stored respectively in liquid nitrogen and -80˚C 
until usage.
Western blot assay proteins
At the specified time points, spinal cord tissues 
were placed in lysis buffer containing 50 mM Tris-
HCl (pH=7.4), 2 mM EDTA, 2 mM EGTA, 10 mM 
NaF, 1 mM sodium orthovanadate (Na3VO4), 10 mM 
β-glycerophosphate, 0.2% W/V sodium deoxycholate, 
1 mM phenylmethylsulfonyl fluoride (PMSF), and 
complete protease inhibitor cocktail (Roche, Germany). 
The homogenate was sonicated on ice with three times 
of 10-seconds bursts at high intensity with a 10-seconds 
cooling period between each burst and then centrifuged 
(10000 g) for 10 minutes at 4˚C. Protein concentration 
was determined by Bradford assay kit (BioRad, USA) and 
adjusted (25).
Each adjusted sample was mixed 1:1 v:v with 2x sodium 
dodecyl sulfate (SDS) blue buffer, boiled, aliquoted and 
kept at -80˚C. Samples were loaded (50 mg of protein/lane), 
electrophoresed in a 12% SDS-polyacrylamide gel (SDS-
PAGE) and blotted to a polyvinylidene fluoride (PVDF) 
membrane (BioRad, USA). The membranes were incubated 
overnight at 4˚C with mouse monoclonal anti-GFAP (Cell 
Signaling, #3670, 1:1000, USA), mouse monoclonal anti-
Iba-1 (Santa Cruz #1022-5, 1:1000, USA), rabbit polyclonal 
anti-Bax (Cell Signaling #2772, 1:1000, USA), rabbit 
polyclonal anti-Bcl2 (Cell Signaling #2870, 1: 1000, USA) 
and rabbit polyclonal anti-β-actin antibodies (Cell Signaling 
#4967, 1: 1000, USA). After washing three times with 
TBST, membranes were incubated with rabbit horseradish 
peroxidase-conjugate anti-rabbit IgG (Cell Signaling #7071, 
1:2000, USA) or anti-mouse IgG (Cell Signaling #7072, 
1:2000, USA). Enhanced chemiluminescence (Pierce, USA) 
was used to visualize the peroxidase-coated bands. The 
integral optical density (IOD) of each band was measured 
using Alliance 4.7 gel-doc (UK), and UVtec software (UK) 
was used for densitometric analysis of the bands. Protein 
levels were normalized against intensity of β-actin protein, 
as control.
Statistical analysis 
All behavioral data are presented as mean ± SEM. 
Statistical evaluation for behavioral data was made by 
two-ways ANOVA with repeated measure, followed by 
Bonferronis’ post hoc test for multiple comparisons. One-
way ANOVA followed by Tukeys’ was used for western 
blot results. Differences were considered statistically 
significant, if P<0.05. Statistical analysis was done by 
Graphpad Prism 6.01 (CA,USA).
Results
Chemical analysis
HPLC fingerprints of the ethanolic extract of L. 
citriodora showed major peaks at the wavelength of 320 
nm, for the retention times (minute) of 7.43, 12.11, 12.51, 
14.2, 15.48 and 15.83 (Fig.1).
Fig.1:  High-performance liquid chromatography (HPLC) fingerprint of the 
ethanolic extract of L. citriodora on the wavelength of 320 nm.
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 Effect of L. citriodora ethanolic extract on the
behavioral signs of neuropathic pain
Mechanical allodynia 
Assessment of behavioral signs of sham-operated 
animals indicated that they were statistically 
indistinguishable from naive animals (data not shown). 
All of the rats had undergone sciatic nerve CCI, exhibited 
decreased thresholds of mechanical allodynia in the 
affected hind paw, 3 days after surgery, as compared to 
sham animals (7.5 ± 0.64 g vs. 48.7 ± 5.62 g, P<0.001 
by two-ways ANOVA). Low dose of ethanolic extract 
(50 mg/kg) did not modify CCI-induced mechanical 
hypersensitivity to Von Frey filaments. Mechanical 
allodynia-like behavior was significantly attenuated in 
100 and 200 mg/kg of ethanolic extract, compared to 
control group on 3-14 days post-operation (P<0.001). 
However, gabapentin at the administrated dose (100 
mg/kg) was not able to efficiently alleviate mechanical 
allodynia after nerve injury (Fig.2A).
Cold allodynia 
By 3 days post-CCI, cold allodynia was developed in 
the ipsilateral paw CCI-NS animals by elevating paw 
withdrawal frequencies, as compared to sham animals 
(84.4 ± 4.4% vs. 4.8 ± 2.9%, P<0.001 by two-ways 
ANOVA). Low dosage of ethanolic extract (50 mg/
kg) did not modify CCI-induced cold allodynia. Cold 
hypersensitivity was reduced in treated animals with 
100 and 200 mg/kg ethanolic extract, on days 3-14 post-
operation, as that observed with gabapentin (100 mg/kg) 
as the reference drug (Fig.2B).
Heat hyperalgesia 
Three days after CCI, ipsilateral paws exhibited 
pronounced thermal hyperalgesia for 14 days after the 
injury, compared to the sham animals (8.5 ± 1.48 seconds 
vs. 27.6 ± 1.47 seconds, P<0.001 by two-ways ANOVA) 
(Fig.2C). As did reference drug gabapentin, ethanolic 
extract (50, 100 and 200 mg/kg) attenuated mean 
withdrawal latency to thermal stimulus, on days 3-14 
after nerve injury.
Fig.2: Effect of L. citriodora ethanolic extract on the CCI-induced 
behavioral changes. Extraxt (50, 100 and 200 mg/kg) was administered 
once per day, from  the day of surgery to 14 day. A. Mechano-allodynia 
in Von-Frey hair test, B. Cold allodynia in acetone drop test, and C. 
Thermal hyperalgesia in radiant heat test on days -1 (one day before 
surgery), 3, 5, 7, 10 and 14 after CCI. Rats received either sham or 
CCI surgery on day 0. Extract was given daily, for 2 weeks from the 
day of surgery. Values are mean ± SEM, n=9 rats per group; data were 
analyzed by two-way ANOVA, followed by Bonferronis’ post hoc test
###; P<0.001 NS-CCI animals vs. sham group, *; P<0.05, **; P<0.01, 
***; P<0.001 extract vs. NS-CCI animals (control group). Gabepentin 
(Gbp) is the reference drug, NS; Normal saline, and CCI; Chronic 
constriction injury.
Effect of L. citriodora ethanolic extract on the spinal 
cord Bax and Bcl-2 proteins
The expression of spinal cord Bax protein was increased 
in NS-CCI animals, 3 days after injury (P<0.01), while no 
obvious change was found in the level of Bcl-2 protein as 
compared to the sham animals. Hence a significant increase 
in the Bax: Bcl-2 protein was detected at this time (Fig.3A, 
B). Treatment of rats with 100 and 200 mg/kg L. citriodora 
ethanolic extract significantly decreased Bax and increased 
Bcl-2 protein levels on day 3. As a result, the ratio of Bax: 
Bcl-2 was attenuated in L. citriodora-CCI-animals (P<0.01 
and P<0.05 for 100 and 200 mg/kg, respectively). Bcl-2 
protein content was increased on day 7 in NS-CCI animals 
(Fig.3C, D). Although Bcl-2 remained elevated in CCI 
animals receiving L. citriodora ethanolic extract, there was 
no significant difference in the Bax: Bcl-2 ratio among the 
groups on days 7 and 14 (data not shown) after the injury.
A
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Fig.3: Effect of L. citriodora ethanolic extract on the expression of Bax and 
Bcl-2 proteins in lumbar spinal cord of chronic constriction injury (CCI) 
animals. Extraxt (50, 100 and 200 mg/kg) was administered once per day, 
from  the day of surgery to 14 day. A, C. Representative western blot of 
Bax/Bcl2 on days 3 and 7  respectively, B, and D. Analysis was carried out 
as described under methods and the bars depict densitometry analyses 
of western blots from three independent experiments. β-actin (42 kDa) is 
the loading control protein. Values are mean ± SEM. Data were analyzed 
by one-way ANOVA, followed by Tukeyss’ post hoc test. 
#; P<0.01, normal saline (NS)-CCI animals vs. sham group, **; P<0.01, and 
*; P<0.05, extracts vs. NS-CCI animals (control group). 
Effect of L. citriodora ethanolic extract on the spinal 
cord GFAP protein
Western blotting results revealed no significant change 
in the GFAP levels on days 3 (Fig.4A, B) and 7 (Fig.4C, 
D) following chronic constriction injury of the sciatic 
nerve (same results for day 14, data not shown).
Fig.4:  Effect of L. citriodora ethanolic extract on the expression of glial fibrillary 
acidic (GFAP) protein in lumbar spinal cord of CCI animals. Extraxt (50, 100 
and 200 mg/kg) was administered once per day, from  the day of surgery to 
14 day. A, C. Representative western blot of iba1 on days 3 and 7 after CCI, 
respectively, B, and D. Analysis was carried out as described under methods 
and the bars depict densitometry analyses of western blots from three 
independent experiments. β-actin (42 kDa) is the loading control protein. 
Values are mean ± SEM. Data were analyzed by one-way ANOVA, followed by 
Tukeyss’ post hoc test.
A
B
C
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Effect of L. citriodora ethanolic extract on the spinal 
cord Iba protein
On day 3 after CCI, the level of Iba, a marker of microglia 
activation, was increased in the spinal cord of CCI-NS rats, as 
compared to sham group (P<0.01, Fig.5A, B). While, this level 
was declined on day 7 (P<0.05, Fig.5C, D) and day 14 after 
CCI (data not shown). Treatment with L. citriodora ethanolic 
extract (100 and 200 mg kg) suppressed the activation of 
microglia 3 and 7 days after surgery, as compared to CCI 
animals receiving NS (P<0.05 for 100 and 200 mg/kg).
Fig.5:  Effect of L. citriodora ethanolic extract on the expression of ionized 
binding (Iba1) protein in lumbar spinal cord of  chronic constriction injury (CCI) 
animals. Extraxt (50, 100 and 200 mg/kg) was administered once per day, 
from  the day of surgery to 14 day. A, C. Representative western blot of iba1 on 
days 3  and 7  after CCI, B, and D. Analysis was carried out as described under 
methods and the the bars depict densitometry analyses of western blots from 
three independent experiments. β-actin (42 kDa) is the loading control protein. 
Values are mean ± SEM. Data were analyzed by one-way ANOVA, followed by 
Tukeyss’ post hoc test.
##; P<0.01 NS-CCI animals vs. sham group, #; P<0.05 NS-CCI animals vs. 
sham group, *; P<0.05 , extracts vs. NS-CCI animals (control group).
Discussion
Our data demonstrated that L. citriodora ethanolic 
extract was unable to increase the pain threshold 
in sham animals, indicating that it has no per se 
analgesic activity. A period of 14 days intraperitoneal 
ethanolic extract of L. citriodora (100 and 200 mg/
kg) in neuropathic pain rats reduced mechanical 
allodynia, cold allodynia and thermal hyperalgesia, 
in comparison with NS-CCI animals which was 
comparable to reference drug, gabapentin. However, 
the attenuation of hypersensitivity to innocuous 
mechanical stimulus was greater than what was 
observed with gabapentin.
 Iba, a marker of spinal microglia activation, was 
elevated in the spinal cord of animals on days 3 and 
7, while it was declined by day 14, following the 
CCI. The time course of microglial activation was 
consistent with previous studies (26). Growing body 
of evidences demonstrated that microglia activation 
within the spinal cord is key modulator in the central 
sensitization of neuropathic pain.
Activation of these cells is characterized by 
morphological modifications and enhanced 
expression of markers, such as OX-42 and Iba-1 (27, 
28). Considering that Iba was increased 3 days after 
the CCI, it appears that microglia activation parallels 
the development of neuropathic pain behaviors. 
In addition, minocycline, a selective inhibitor of 
microglia activation and pentoxifylline, an inhibitor 
of cytokine release, prevented mechanical and cold 
allodynia in the CCI rats, besides the inhibition of 
spinal cord microglia activation (29). In contrast, 
there was no difference in the content of GFAP 
among sham, CCI animals and verbascoside-treated 
groups 3, 7 or 14 days after surgery. Our data are in 
agreement with the results of Wodarski et al. (30), 
indicating that the levels of GFAP did not change 
after STZ-induced neuropathic pain in diabetic 
rats. In addition, in an investigation performed 
by Mika et al. (31), significant up-regulation of 
OX42 (a microglia marker) and no or little change 
in GFAP was determined via western blot and 
immunohistochemical analyses, in the ipsilateral 
dorsal lumbar spinal cord of CCI rats. A very large 
increase in the expression of spinal cord microglia 
marker CD11b/c and no change in the astroglial 
marker, GFAP, were reported in the morphine-treated 
CCI mice, as compared to naive animals (32).
However, studies on the activation of GFAP after 
nerve injury are controversial and require further 
investigations. There are many studies claiming that 
astroglia are activated after microglia activation in 
different kinds of peripheral or central nerve injuries 
(33, 34). The observed discrepancies might be due 
to the possibility of astrocyte activation in CCI rat 
spinal cord at a time point, which was not measured 
A
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in our study. Le Coz et al. (35) reported while mRNA 
expression of Iba was increased 4 and 21 days after L4-L5 
spinal cord injury in three strains of rat, no significant up-
regulation or difference in GFAP expression was observed 
in two strains of rat on day 4. Although, a significant GFAP 
up-regulation was detected 21 days after nerve injury in 
only Wistar rat.
Another reason for such difference might be due to 
the variability in the models of induction of neuropathic 
pain. Most of the studies implicated that similar site for 
the injury and damage, while in the sciatic nerve CCI, 
changes are secondary and far from the site of injury. 
This may explain low activation of spinal astrocytes in 
the peripheral nerve CCI (36). A marked increase in Bax 
protein and a slight decrease in Bcl-2 protein level were 
detected 3 days after CCI. Consequently, Bax/Bcl-2 ratio 
was significantly increased in animals subjected to the 
CCI, at this time. Ethanolic extract of L. citriodora (100 
and 200 mg/kg) for 14 days was capable to normalize the 
increased Bax/Bcl-2 ratio observed in the CCI animals, at 
this time. Bax/Bcl-2 ratio was declined thereafter on days 
7 and 14, while no difference was detected among NS-
CCI, sham and neuropathic animals treated with extracts 
in these days. Our data in the present study supports the 
evidence that development of neuropathic pain might be 
associated with the activation of apoptosis process, in 
the CCI of sciatic nerve (17). The association between 
neuronal apoptosis in the dorsal horn and the appearance 
of allodynia or hyperalgesia has not been known yet. 
Apoptosis may cause changes in the structure of neurons, 
resulting in the increased sensitivity of the nociceptive 
system and subsequently induction of hyperalgesia or 
allodynia (37). However, there are differences in the 
pattern of apoptosis occurrence, depending on the time 
point of study. It seems that as a modulatory mechanism, 
mitochondrion induced apoptotic process is limited to 
the first few days after nerve injury. This is in agreement 
with some of the previous studies. In a study performed 
by de Novellis et al. (38), an early apoptosis (2-3 days 
post-CCI) was transiently occurred by the increased ratio 
of bax/bcl-2 genes. An inversed pattern of bcl-2 family 
genes expression was detected at later stages. Increased 
anti-apoptotic expressions, bcl-2 and bcl-xL, resulted in 
the decreased bax/bcl-2 and bcl-Xs/bcl-xL ratios over the 
time. As reported by Costa et al. (39), the increased ratio 
of bax/bcl-2 genes in the spinal cord of CCI rats was also 
limited to the first few days after nerve injury.
Although the level of pro-apoptotic protein, Bax, was 
decreased after day 3 and that of microglia marker, Iba, 
pain related behavior progressively was increased after 7 
day, it did not strictly correlate to these factors. Several 
substances including reactive ROS, cyclooxygenase, 
nitric oxide (NO) and pro-inflammatory cytokines (TNF-α 
and IL-1β) are released upon the activation of microglia. 
All of these factors are implicated in pain facilitation and 
hence, development and maintenance of chronic pain (40, 
41). HPLC-DAD analysis showed 5 major picks at 320 
nm, suggesting the presence of phenylpropanoids. This 
result is accordance with Bilia et al. (20) study, reporting 
picks at 330 nm for phenylpropanoids (verbascoside and 
isoverbascoside) and 350 nm for detection of flavonoids. 
All of these compounds showed anti-oxidant activity in 
2,2-diphenyl-1-picrylhydrazyl (DPPH) assay.
Anti-oxidant and anti-inflammatory effects of L. 
citriodora and its bioactive ingredients have been 
demonstrated in various investigations. In a DPPH assay 
on the blood of rats, L. citriodora increased anti-oxidant 
enzymes activities, including catalase (CAT), glutathione 
peroxidase (GPx) and glutathione reductase (GRed). In 
contrast, it decreased myeloperoxidase (MPO) activity, 
as a marker of inflammation. The phenylpropanoids 
verbascoside and isoverbascoside, as well as their 
metabolites were found to be the main constituents 
responsible for the anti-oxidant effects of this plant (11). 
In an in vitro model of Parkinson’s disease, simultaneous 
treatment with verbascoside, markedly attenuated 
methyl-4-phenylpyridinium ion induced apoptotic death, 
oxidative stress and the activation of caspase-3 (42). 
Verbascoside was more active than ibuprofen in the 
acetic acid-induced writhing test and showed similar 
effects in the tail flick test (16). Studies of Casamassima 
et al. indicated that plasma oxidative status in lambs 
supplemented with L. citriodora extracts decreased 
the reactive oxygen metabolites, thiobarbituric acid-
reactive substances and markedly increased the serum 
content of vitamins A and E (43). Following treatment of 
macrophage cells with verbascoside, LPS-induced release 
of NO and increased levels of the inducible nitric oxide 
synthase (iNOS) were inhibited (44). Verbascoside has 
been reported to inhibit apoptosis in galactosamine and 
lipopolysaccharide-induced liver injury (45). In a recent 
study on rats subjected to ligature-induced periodontitis, 
verbascoside reduced cells nuclear factor kappa B (NF-
kB), a protein complex that controls production of many 
pro-inflammatory cytokine, iNOS expression, Bax: Bcl-2 
ratio, as well as the degree of gingivomucosal tissue injury 
(46). Although most of beneficial effects of lemon verbena 
are attributed to verbascoside, other components such as 
phenolic compounds (i.e. phenolic acids and a flavonoid 
glycoside, luteolin) were also reported to be responsible for 
anti-inflammatory effects of L. citriodora (47).
Fourteen days after administration of L. citriodora 
ethanolic extract, tolerance was not determined and the 
anti-hyperalgesic and anti-allodynic effects were still 
evident up to the end of study. It is therefore unlikely 
that relief of the nociceptive responses, induced by 
verbascoside, could be attributed to opioid receptors. 
Isacchi et al. (48) also reported that anti-hyperalgesic 
effect of main bioactive compound, verbascoside, was not 
prevented by the opioid antagonist naloxone, suggesting 
that the opioid system has a limited or no role in the anti-
hyperalgesic effects of verbascoside.
Conclusion
L. citriodora could be a good option as an adjunctive 
Cell J, Vol 19, No 4, Jan-Mar (Winter) 2018 535
Lippia citriodora Antinociceptive Effects
therapy in the treatment of neuropathic pain. Anti-
nociceptive effects of ethanolic extract of L. citriodora 
can be attributed, at least in part, to the anti-apoptotic and 
microglia inhibiting activities.
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